CA Patent

CA2642414A1 — Rapid release irbesartan-containing pharmaceutical composition

Assigned to Ratiopharm GmbH · Expires 2007-08-23 · 19y expired

What this patent protects

The present invention relates to an irbesartan-containing pharmaceutical composition, in particular a tablet thereof, which comprises the active ingredient, a disintegrant with at least one low-substituted hydroxypropylcellulose.

USPTO Abstract

The present invention relates to an irbesartan-containing pharmaceutical composition, in particular a tablet thereof, which comprises the active ingredient, a disintegrant with at least one low-substituted hydroxypropylcellulose.

Drugs covered by this patent

Patent Metadata

Patent number
CA2642414A1
Jurisdiction
CA
Classification
Expires
2007-08-23
Drug substance claim
No
Drug product claim
No
Assignee
Ratiopharm GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.